Alnylam Pharmaceuticals (ALNY) Property, Plant & Equipment (Net) (2009 - 2026)

Alnylam Pharmaceuticals (ALNY) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.96 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 34.61 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.64 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3.76 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 554.14 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 107.22 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn 11.32 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 554.14 Mn
Jun 30, 2026 554.14 Mn
Mar 31, 2026 518.26 Mn
Mar 31, 2026 518.26 Mn
Dec 31, 2025 513.15 Mn
Dec 31, 2025 513.15 Mn
Sep 30, 2025 501.75 Mn
Sep 30, 2025 501.75 Mn
Jun 30, 2025 499.79 Mn
Jun 30, 2025 499.79 Mn
Mar 31, 2025 498.68 Mn
Mar 31, 2025 498.68 Mn
Dec 31, 2024 502.78 Mn
Dec 31, 2024 502.78 Mn
Sep 30, 2024 507.00 Mn
Sep 30, 2024 507.00 Mn
Jun 30, 2024 517.16 Mn
Jun 30, 2024 517.16 Mn
Mar 31, 2024 523.46 Mn
Mar 31, 2024 523.46 Mn